KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) EBITDA Margin (2016 - 2025)

Amgen (AMGN) has 17 years of EBITDA Margin data on record, last reported at 27.57% in Q4 2025.

  • For Q4 2025, EBITDA Margin rose 213.0% year-over-year to 27.57%; the TTM value through Dec 2025 reached 24.71%, up 299.0%, while the annual FY2025 figure was 24.71%, 299.0% up from the prior year.
  • EBITDA Margin reached 27.57% in Q4 2025 per AMGN's latest filing, up from 26.43% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 40.08% in Q1 2022 and bottomed at 12.69% in Q2 2021.
  • Average EBITDA Margin over 5 years is 28.06%, with a median of 29.11% recorded in 2023.
  • Peak YoY movement for EBITDA Margin: crashed -2474bps in 2021, then surged 2031bps in 2022.
  • A 5-year view of EBITDA Margin shows it stood at 33.65% in 2021, then dropped by -3bps to 32.61% in 2022, then plummeted by -52bps to 15.51% in 2023, then surged by 64bps to 25.43% in 2024, then grew by 8bps to 27.57% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 27.57% in Q4 2025, 26.43% in Q3 2025, and 28.94% in Q2 2025.